Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.000
-0.020 (-0.66%)
Jun 3, 2026, 10:34 AM EDT - Market open
Cyclerion Therapeutics Market Cap
Cyclerion Therapeutics has a market cap or net worth of $12.72 million as of June 3, 2026. Its market cap has increased by 30.38% in one year.
Market Cap
12.72M
Enterprise Value
9.94M
1-Year Change
30.38%
Ranking
Category
Stock Price
$3.00
Market Cap Chart
Since March 18, 2019, Cyclerion Therapeutics's market cap has decreased from $193.31M to $12.72M, a decrease of -93.42%. That is a compound annual growth rate of -31.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 2, 2026 | 12.81M | 164.98% |
| Dec 31, 2025 | 4.83M | -40.68% |
| Dec 31, 2024 | 8.15M | -0.51% |
| Dec 29, 2023 | 8.19M | -71.30% |
| Dec 30, 2022 | 28.54M | -61.69% |
| Dec 31, 2021 | 74.50M | -28.31% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AIM ImmunoTech | 14.15M |
| MetaVia | 14.10M |
| Moleculin Biotech | 14.09M |
| CytoMed Therapeutics | 13.50M |
| Lunai Bioworks | 13.42M |
| Chemomab Therapeutics | 13.39M |
| CalciMedica | 13.26M |
| Phio Pharmaceuticals | 13.13M |